A recent meta-analysis about the efficacy of GLP-1 agonists in obesity and DMT2 concluded that GLP-1 agonists demonstrate modest effects on the glycemic control and weight loss; the authors attributed those findings to the low drug dosage [30]. This evidence concerns the gene GCG and Obesity.